Lebel Carl
SEC-identified person · CIK 1439275 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Korro Bio, Inc. KRRO | Chief Development Officer | filed 2019 - 2023 |
| Otonomy, Inc. OTIC | Chief Scientific Officer | filed 2014 - 2016 |
| Quest Group International INC QSTG | Director | filed 2010 - 2010 |
| Akesis Pharmaceuticals, INC. AKES.OB | Director · President and COO | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.